Setup, so nobody has to ask: 10 mg/mL · cagrilintide.
I suspect the honest answer is that it depends, in which case I would like to know on what.
Assume I can obtain either option without difficulty, so availability is not the deciding factor.
Is there a defensible reason to prefer one, or is this a coin flip?
At 10 mg/mL a 0.25 mg draw is 2.5 units on a U-100 barrel and a 2.4 mg draw is 24. Those two numbers decide it, because the concentration is only sensible relative to the smallest and largest volumes you will actually measure with it. 2.5 units is too little of the scale to read honestly — half a graduation is 20 per cent of that dose — so going lower in concentration buys resolution you cannot get back after reconstitution. The other consideration is time: a vial you will finish in a fortnight can be concentrated, and a vial you will draw from for months should be split at reconstitution instead.
Start from the dose you intend to draw and work backwards to the volume that puts it in a readable part of the barrel.
For a dose that will change during titration, choose the volume for the largest intended dose rather than the first, so the whole schedule fits on one barrel without a mid-vial recalculation.
| Vial | Diluent | Concentration | 0.25 mg | 0.5 mg | 1 mg | 2.5 mg |
|---|---|---|---|---|---|---|
| 5 mg | 1 mL | 5 mg/mL | 5 u | 10 u | 20 u | 50 u |
| 5 mg | 2 mL | 2.5 mg/mL | 10 u | 20 u | 40 u | 100 u |
| 10 mg | 1 mL | 10 mg/mL | 2.5 u | 5 u | 10 u | 25 u |
| 10 mg | 2 mL | 5 mg/mL | 5 u | 10 u | 20 u | 50 u |
| 10 mg | 3 mL | 3.33 mg/mL | 7.5 u | 15 u | 30 u | 75 u |
Units are U-100 insulin units, where 1 unit = 0.01 mL. Divide dose by concentration for millilitres, then multiply by 100.
Put another way, dead-space loss scales with the number of draws, not with the concentration, so a lower concentration spread over more draws loses proportionally less of the total peptide.
Published content assay results across the independent testing services show nominal and measured content differing by one to ten per cent, which makes content the dominant term in dose error.
Do not change the diluent volume between vials of a titration without recalculating; it is the commonest source of a ten-fold error.
Write the concentration on the label at reconstitution, in units per dose.
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standardsThe short version: more diluent means a lower concentration, a larger volume per dose and a finer reading; less means the opposite.
The other direction: 10 mg in 3 mL is 3.33 mg/mL, and a 0.5 mg dose becomes 0.15 mL, or 15 units. More barrel, easier reading, and a larger fraction of the vial volume lost to dead space across the same number of draws.
Write the concentration and the resulting units-per-dose on the vial label at reconstitution. The arithmetic that is obvious now will not be obvious at six in the morning three weeks from now.
The caveat is that this arithmetic assumes the vial contains what the label says, and without a content assay it is precise about an unknown quantity.
Measure a volume you can actually measure. Round numbers, real syringes.
Answering this needs the syringe you actually own, because the barrel graduations decide what "readable" means.
Round to a diluent volume you can measure accurately. Measuring 1.00 mL on a 1 mL syringe is reliable; measuring 1.37 mL on anything is not, and the error propagates into every dose.
Specifically, worked example. A 10 mg vial reconstituted with 2 mL gives 5 mg/mL. A 0.5 mg dose is 0.5 ÷ 5 = 0.1 mL, which on a U-100 syringe is 10 units. Reconstitute the same vial with 1 mL and the concentration doubles to 10 mg/mL, the same dose becomes 0.05 mL, and you are now reading 5 units instead of 10 — the same dose at half the resolution.
Nominal vial volumes in the standard 2R and 3R glass sizes have published brimful capacities well above the nominal fill, but the usable volume is bounded by the stopper displacement.
Nothing here is medical advice, and research-use material is not approved for human use.
Check the vial can physically hold the volume before you draw it up.
edited 4 Aug 2024 by bac_or_bust — added the method parameters
The relevant arithmetic is concentration equals vial content divided by diluent volume, and content is not the same as label claim.
Vial headspace is the hard constraint. A nominal 2 mL vial typically holds a little over 2 mL to the shoulder; adding 3 mL is not an option and attempting it wastes the lot.
Insulin syringe barrel graduations are typically 1 unit on a 0.3 mL barrel, 1 unit on a 0.5 mL barrel and 2 units on a 1 mL barrel, which is why the barrel size changes what is readable.
Choose the volume that puts your largest intended dose between 10 and 30 units. Everything else follows.
This is the one decision in the whole preparation sequence that cannot be revised later, which is why it is worth thirty seconds of arithmetic.
Content matters. If the same 10 mg vial assays at 94 per cent content, you have 9.4 mg. In 2 mL that is 4.7 mg/mL, and a nominal 0.5 mg draw of 10 units actually delivers 0.47 mg — a six per cent shortfall that no amount of careful drawing will fix.
U-100 means 100 units per millilitre by definition, so 1 unit is 0.01 mL and volume in millilitres times one hundred gives units. Every conversion here reduces to that.
Concentration equals content over volume, and content is not label claim.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.